Retatrutide 10mg
99.682% HPLC PurityA triple GLP-1, GIP and glucagon receptor agonist, supplied as a 10mg lyophilised vial.

SKU: PEP-034-5MG
A synthetic fragment of the C-terminal region of human growth hormone (residues 177–191), supplied as a 5mg lyophilised vial. Research use only. Preorder — ships with the first batch.
Read the full description ↓Price includes GST
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Preorder: dispatched once the next batch arrives, tracked with Australia Post
A triple GLP-1, GIP and glucagon receptor agonist, supplied as a 10mg lyophilised vial.
The same triple receptor agonist as our 10mg vial, supplied at double the strength.
The same triple receptor agonist as our 10mg vial, supplied at triple the strength.
A synthetic fragment of the C-terminal region of human growth hormone (residues 177–191), supplied as a 5mg lyophilised vial.
It has been studied in lipid-metabolism models as a growth hormone fragment designed to lack the parent hormone's other activities.
This product is currently available to preorder and ships once the first batch has been produced and tested. Strictly for in-vitro laboratory research only.
A synthetic fragment of the C-terminal region of human growth hormone (residues 177–191), supplied as a 5mg lyophilised vial. It has been studied in lipid-metabolism models as a growth hormone fragment designed to lack the parent hormone's other activities. All use is strictly for in-vitro laboratory research only.
This product is a preorder. It is not held in stock yet and ships with the first batch; you will be emailed when your order is dispatched.
Batch testing documentation is published for each batch once it has been produced and tested. Contact us before ordering if you need it first.
Store lyophilised product at −20°C, protected from light and moisture, and avoid repeated freeze-thaw cycles.
No. AOD-9604 is supplied for in-vitro laboratory research only and is not approved for human consumption or therapeutic use. Scheduling attaches to the substance and changes over time; verify the current status against the TGA Poisons Standard.
AOD-9604 5mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
No questions yet — be the first to ask about this product.
Recent peer-reviewed studies from PubMed related to AOD-9604. Provided for research context — not medical advice.
AOD-9604 Metabolic
Wilding J · Current opinion in investigational drugs (London, England : 2000) · 2004
PMID: 15134286
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
Rahman OF, Lee SJ, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
PMID: 41490200
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance
Mendias CL, Awan TM · Sports medicine (Auckland, N.Z.) · 2026
PMID: 41966639
AOD-9604 does not influence the WADA hGH isoform immunoassay
Orlovius AK, Thomas A, Schänzer W, et al. · Drug testing and analysis · 2013
PMID: 24124033
Source: U.S. National Library of Medicine (PubMed). Citations are fetched live and cached; inclusion does not imply endorsement of any therapeutic use.